Joseph Newcomer, MD
Orthopaedic Surgery · Bloomington, ILNPI 1285633420
Payments from drug & device makers
Across 59 payments — averaging $117.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$4K
- Stryker$1K
- Wardlow Enterprises$873
- Johnson & Johnson$408
- Zimmer Biomet$344
- Zynex Medical, Inc.$189
- plus $449 from 11 others
What the payments were for
- Travel & lodging$1,78526%
- Food & beverage$2,18331%
- Education$2,34634%
- Gifts$6449%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 20 | $3,673 |
| Stryker(2 entities) | 8 | $1,024 |
| Wardlow Enterprises | 5 | $873 |
| Johnson & Johnson | 7 | $408 |
| Zimmer Biomet | 2 | $344 |
| Zynex Medical, Inc. | 1 | $189 |
| Heraeus Medical, LLC. | 2 | $147 |
| Baudax Bio Inc. | 3 | $58 |
| Motive Health, Inc. | 1 | $50 |
| Vericel Corporation | 2 | $44 |
| Osteocentric Technologies, Inc. | 1 | $38 |
| Pacira Therapeutics, Inc. | 2 | $24 |
| Myoscience Inc. | 1 | $22 |
| Convatec Inc. | 1 | $19 |
| Orthofix Medical, Inc. | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Ferring Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SIMPLICITI$644
- Persona$200
- Nexwave$189
- ROSA$144
- Velys$128
- INFINITY ADAPTIS$108
How this compares
$6,958 in reported general payments places this provider in the 65th percentile of 844 orthopaedic surgery providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 11 | $240 |
| Meloxicam | 79 | $151 |
| Amoxicillin | 51 | $48 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Bloomington
- Peter BonuttiEffingham$24.3M
- Steven HaddadGlenview$12.6M
- Aaron RosenbergChicago$12.4M
- Treg BrownHerrin$6.6M
- Kamal IbrahimOakbrook Terrace$4.9M
- Wayne GoldsteinMorton Grove$4.9M
- Steven MatherDowners Grove$4.3M
- Steven MardjetkoMorton Grove$4.3M
- Steven ChudikWestmont$4.1M
- Matthew SquireAurora$2.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.